vs

Side-by-side financial comparison of NewtekOne, Inc. (NEWT) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

NewtekOne, Inc. is the larger business by last-quarter revenue ($73.3M vs $41.8M, roughly 1.8× Neuronetics, Inc.). NewtekOne, Inc. runs the higher net margin — 111.8% vs -17.2%, a 129.0% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -2.7%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-579.3M). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 12.2%).

NewTek, Inc., is a hardware and software company, based in San Antonio, Texas, that produced live and post-production video tools and visual imaging software for personal computers. The company was founded in 1985 in Topeka, Kansas, United States, by Tim Jenison and Paul Montgomery. On April 1, 2019, it was announced that NewTek would be acquired by Vizrt.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

NEWT vs STIM — Head-to-Head

Bigger by revenue
NEWT
NEWT
1.8× larger
NEWT
$73.3M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+88.4% gap
STIM
85.7%
-2.7%
NEWT
Higher net margin
NEWT
NEWT
129.0% more per $
NEWT
111.8%
-17.2%
STIM
More free cash flow
STIM
STIM
$580.0M more FCF
STIM
$692.0K
$-579.3M
NEWT
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
12.2%
NEWT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NEWT
NEWT
STIM
STIM
Revenue
$73.3M
$41.8M
Net Profit
$19.5M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
111.8%
-17.2%
Revenue YoY
-2.7%
85.7%
Net Profit YoY
6.6%
43.2%
EPS (diluted)
$0.64
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NEWT
NEWT
STIM
STIM
Q4 25
$73.3M
$41.8M
Q3 25
$74.9M
$37.3M
Q2 25
$70.2M
$38.1M
Q1 25
$66.3M
$32.0M
Q4 24
$75.4M
$22.5M
Q3 24
$62.8M
$18.5M
Q2 24
$61.1M
$16.4M
Q1 24
$58.3M
$17.4M
Net Profit
NEWT
NEWT
STIM
STIM
Q4 25
$19.5M
$-7.2M
Q3 25
$17.9M
$-9.0M
Q2 25
$13.7M
$-10.1M
Q1 25
$9.4M
$-12.7M
Q4 24
$18.3M
$-12.7M
Q3 24
$11.9M
$-13.3M
Q2 24
$10.9M
$-9.8M
Q1 24
$9.7M
$-7.9M
Gross Margin
NEWT
NEWT
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
NEWT
NEWT
STIM
STIM
Q4 25
-12.1%
Q3 25
-19.6%
Q2 25
-21.1%
Q1 25
-34.4%
Q4 24
-51.0%
Q3 24
-41.7%
Q2 24
-51.7%
Q1 24
-39.4%
Net Margin
NEWT
NEWT
STIM
STIM
Q4 25
111.8%
-17.2%
Q3 25
23.9%
-24.3%
Q2 25
19.5%
-26.6%
Q1 25
14.1%
-39.6%
Q4 24
24.3%
-56.4%
Q3 24
19.0%
-72.0%
Q2 24
17.9%
-59.8%
Q1 24
16.6%
-45.2%
EPS (diluted)
NEWT
NEWT
STIM
STIM
Q4 25
$0.64
$-0.10
Q3 25
$0.67
$-0.13
Q2 25
$0.52
$-0.15
Q1 25
$0.35
$-0.21
Q4 24
$0.70
$-0.34
Q3 24
$0.45
$-0.44
Q2 24
$0.43
$-0.33
Q1 24
$0.38
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NEWT
NEWT
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$28.1M
Total DebtLower is stronger
$819.9M
$65.8M
Stockholders' EquityBook value
$397.6M
$22.4M
Total Assets
$2.7B
$141.6M
Debt / EquityLower = less leverage
2.06×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NEWT
NEWT
STIM
STIM
Q4 25
$28.1M
Q3 25
$28.0M
Q2 25
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Q1 24
$47.7M
Total Debt
NEWT
NEWT
STIM
STIM
Q4 25
$819.9M
$65.8M
Q3 25
$748.5M
$65.7M
Q2 25
$657.3M
$55.5M
Q1 25
$774.0M
$55.3M
Q4 24
$708.0M
$55.2M
Q3 24
$655.8M
$46.0M
Q2 24
$652.0M
$59.8M
Q1 24
$662.5M
$59.4M
Stockholders' Equity
NEWT
NEWT
STIM
STIM
Q4 25
$397.6M
$22.4M
Q3 25
$386.7M
$27.4M
Q2 25
$312.2M
$27.1M
Q1 25
$302.3M
$35.5M
Q4 24
$296.3M
$27.7M
Q3 24
$281.8M
$9.4M
Q2 24
$274.0M
$19.4M
Q1 24
$254.1M
$27.7M
Total Assets
NEWT
NEWT
STIM
STIM
Q4 25
$2.7B
$141.6M
Q3 25
$2.4B
$145.5M
Q2 25
$2.1B
$134.7M
Q1 25
$2.1B
$142.0M
Q4 24
$2.1B
$140.9M
Q3 24
$1.7B
Q2 24
$1.6B
$96.8M
Q1 24
$1.5B
$103.8M
Debt / Equity
NEWT
NEWT
STIM
STIM
Q4 25
2.06×
2.94×
Q3 25
1.94×
2.40×
Q2 25
2.11×
2.05×
Q1 25
2.56×
1.56×
Q4 24
2.39×
1.99×
Q3 24
2.33×
4.90×
Q2 24
2.38×
3.08×
Q1 24
2.61×
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NEWT
NEWT
STIM
STIM
Operating Cash FlowLast quarter
$-579.2M
$908.0K
Free Cash FlowOCF − Capex
$-579.3M
$692.0K
FCF MarginFCF / Revenue
-790.0%
1.7%
Capex IntensityCapex / Revenue
0.1%
0.5%
Cash ConversionOCF / Net Profit
-29.64×
TTM Free Cash FlowTrailing 4 quarters
$-1.0B
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NEWT
NEWT
STIM
STIM
Q4 25
$-579.2M
$908.0K
Q3 25
$-167.3M
$-785.0K
Q2 25
$-199.8M
$-3.5M
Q1 25
$-60.7M
$-17.0M
Q4 24
$-153.0M
$-8.6M
Q3 24
$-25.7M
$-5.4M
Q2 24
$2.9M
$-5.0M
Q1 24
$-38.7M
$-12.0M
Free Cash Flow
NEWT
NEWT
STIM
STIM
Q4 25
$-579.3M
$692.0K
Q3 25
$-167.3M
$-899.0K
Q2 25
$-199.9M
$-3.8M
Q1 25
$-60.7M
$-17.2M
Q4 24
$-153.5M
$-8.7M
Q3 24
$-25.9M
$-5.8M
Q2 24
$2.9M
$-5.6M
Q1 24
$-38.7M
$-12.4M
FCF Margin
NEWT
NEWT
STIM
STIM
Q4 25
-790.0%
1.7%
Q3 25
-223.3%
-2.4%
Q2 25
-284.7%
-9.9%
Q1 25
-91.6%
-53.8%
Q4 24
-203.6%
-38.6%
Q3 24
-41.2%
-31.3%
Q2 24
4.7%
-34.0%
Q1 24
-66.5%
-71.1%
Capex Intensity
NEWT
NEWT
STIM
STIM
Q4 25
0.1%
0.5%
Q3 25
0.0%
0.3%
Q2 25
0.1%
0.7%
Q1 25
0.1%
0.7%
Q4 24
0.6%
0.4%
Q3 24
0.4%
2.1%
Q2 24
0.1%
3.7%
Q1 24
0.1%
2.2%
Cash Conversion
NEWT
NEWT
STIM
STIM
Q4 25
-29.64×
Q3 25
-9.35×
Q2 25
-14.58×
Q1 25
-6.48×
Q4 24
-8.35×
Q3 24
-2.15×
Q2 24
0.27×
Q1 24
-4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons